Plenti-ARE-HSVTK-luc Citations (1)

Originally described in: The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Sanghvi VR, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, Miele MM, Lailler N, Zhao C, de Stanchina E, Viale A, Akkari L, Lowe SW, Ciriello G, Hendrickson RC, Wendel HG Cell. 2019 Aug 8;178(4):807-819.e21. doi: 10.1016/j.cell.2019.07.031. PubMed Journal

---

Articles Citing Plenti-ARE-HSVTK-luc

Articles
ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2. Luo M, Bao L, Xue Y, Zhu M, Kumar A, Xing C, Wang JE, Wang Y, Luo W. J Clin Invest. 2024 Jan 23;134(6):e171166. doi: 10.1172/JCI171166. PubMed

If you have published an article using this material, please email us at to have your article added to this page.